Posted on August 17th, 2011 by Health News
The U.S. Food and Drug Administration today approved Zelboraf (vemurafenib), a drug to treat patients with late-stage (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
Read more
Filed under: Pharmacy News
Tags: cancer, Drug, Pharmacy, skin cancer
Related posts
- Single dose of Pain Therapeutics’ PTI-188 decreased melanoma tumors: Study (0)
Pain Therapeutics, Inc. today announced encouraging clinical data with PTI-188, an early-stage drug for metastatic melanoma. Metastatic melanoma is a lethal form of skin cancer in which patients typically have a median survival time of 9 months.
Read more
[tags] Pharmacy News [/tags]
- Scientists develop new type of anti-cancer drug (0)
A team of University of Hawaii Cancer Center scientists led by James Turkson, Ph.D. have created a new type of anti-cancer drug named BP-1-102. The drug, which can be orally administered, targets a key protein that triggers the development of many types of cancer including lung, breast and skin cancers.
Read more
[tags] Pharmacy News [/tags]
- Rush University enrolls first U.S. patient in international clinical trial for melanoma (0)
Rush University Medical Center has just enrolled the first U.S. patient in an international clinical trial testing a novel drug to treat certain kinds of melanoma, a deadly skin cancer that in its advanced stages currently has few effective treatments.
Read more
[tags] Pharmacy News [/tags]
- Roche’s skin cancer drug Erivedge gets FDA nod (0)
The Food and Drugs Administration (FDA) this Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma.
Read more
[tags] Pharmacy News [/tags]
- Powerful X-rays help develop new drug treatment for malignant melanoma (0)
Powerful X-ray technology developed at the U.S. Department of Energy's (DOE's) national laboratories is revealing new insights into diseases ranging from Alzheimer's to the swine flu, and, most recently, enabled the discovery of a groundbreaking new drug treatment for malignant melanoma, the deadliest form of skin cancer.
Read more
[tags] Pharmacy News [/tags]
Leave a Reply